
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Shire BioChem, Inc., Laval, Québec, H7V 4A7 Canada [Y. T., Q. Y., D. C., H. G.]; The Institute for Molecular Virology, St. Louis University Medical Center, St. Louis, Missouri 63110 [L. K. V., G. C.]; and Apoptosis Technology, Inc., Cambridge, Massachusetts 02139 [C. V., T. C.]
The Bcl-2 homology 3 (BH3) domain is present in most members of the Bcl-2 protein family and is required to confer the death-inducing properties of pro-apoptotic members, including Bax, Bak, Bad, and Bik, in cell-based assay systems. To determine whether the BH3 domain possesses a similar role in tumor tissues in vivo, we overexpressed the wild-type Bik protein and its BH3-deleted counterpart, using adenoviral technology, in chemoresistant human tumor prostate (PC-3) and colon (HT-29) cell lines growing in vitro and in vivo. Bik caused apoptosis in both PC-3 and HT-29 cells in vitro by inducing the release of cytochrome c from mitochondria to cytoplasm, resulting in the catalytic activation of caspases 9, 7, and 3 and cleavage of poly(ADP-ribose) polymerase and DNA fragmentation. When the BH3 domain was deleted from the Bik protein, no effect on mitochondrial activity or cell morphology could be observed. Furthermore, intratumoral injection of an adenovirus vector expressing the Bik gene, but not the deleted BH3 Bik gene, suppressed the growth of PC-3 and HT-29 xenografts established in nude mice. Histological examination of tumors from mice treated with the wild-type Bik adenoviral construct demonstrated cellular debris, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling positive staining, and morphological changes associated with apoptosis. In contrast, tissue sections obtained from tumors treated with the BH3-deleted Bik adenoviral construct showed no evidence of apoptosis. Thus, our results suggest that the BH3 domain is required for the antitumor activity of the Bik protein and provides a novel therapeutic approach for cancer therapy.
This article has been cited by other articles:
![]() |
B. Gillissen, F. Essmann, P. G. Hemmati, A. Richter, A. Richter, I. Oztop, G. Chinnadurai, B. Dorken, and P. T. Daniel Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis J. Cell Biol., November 19, 2007; 179(4): 701 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-Y. Kim, S. Zhong, C. R. Fields, J. H. Kim, and K. D. Robertson Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res., August 1, 2006; 66(15): 7490 - 7501. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tesfaigzi Roles of Apoptosis in Airway Epithelia Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 537 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yui, T. Saeki, R. Kanamoto, and K. Iwami Characteristics of Apoptosis in HCT116 Colon Cancer Cells Induced by Deoxycholic Acid J. Biochem., August 1, 2005; 138(2): 151 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hur, J. Chesnes, K. R. Coser, R. S. Lee, P. Geck, K. J. Isselbacher, and T. Shioda The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis PNAS, February 24, 2004; 101(8): 2351 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Wilson, D. Arango, J. M. Mariadason, B. G. Heerdt, and L. H. Augenlicht TR3/Nur77 in Colon Cancer Cell Apoptosis Cancer Res., September 1, 2003; 63(17): 5401 - 5407. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Milutinovic, Q. Zhuang, A. Niveleau, and M. Szyf Epigenomic Stress Response. KNOCKDOWN OF DNA METHYLTRANSFERASE 1 TRIGGERS AN INTRA-S-PHASE ARREST OF DNA REPLICATION AND INDUCTION OF STRESS RESPONSE GENES J. Biol. Chem., April 18, 2003; 278(17): 14985 - 14995. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Theodorakis, E. Lomonosova, and G. Chinnadurai Critical Requirement of BAX for Manifestation of Apoptosis Induced by Multiple Stimuli in Human Epithelial Cancer Cells Cancer Res., June 1, 2002; 62(12): 3373 - 3376. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |